Clinical Trials
59 trialsFRE
Hackensack Meridian Health
E-STOP2
Hospital Universitari Vall d'Hebron Research Institute
ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
Case Comprehensive Cancer Center
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Shaare Zedek Medical Center
Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
Instituto de Investigación Biomédica de Salamanca
ELSA-FN
Murdoch Childrens Research Institute
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Gadjah Mada University
ELSA-Adult
Peter MacCallum Cancer Centre, Australia
ANC-IIT-004
Affiliated Hospital of Nantong University
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Gadjah Mada University
Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer
Rigshospitalet, Denmark
Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial)
The University of Hong Kong
ONFIRE
Hospital Universitari de Bellvitge
REACT
The Christie NHS Foundation Trust
AFFECT-1
Radboud University Medical Center
AFFECT-2
Radboud University Medical Center
Antimicrobial Revision in Persistent Febrile Neutropenia
Wake Forest University Health Sciences
DAR-ARC
Centre Hospitalier Universitaire Vaudois
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
University of Leeds
SAFE
Universitaire Ziekenhuizen KU Leuven
END
Brigham and Women's Hospital
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
Tianjin Medical University Cancer Institute and Hospital
Lapelga vs Gastrofil
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
Assiut University
New Diagnostics in Neutropenia
The University of Queensland
AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients
Centre Hospitalier Universitaire de Nice
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
The First Affiliated Hospital with Nanjing Medical University
Host RNA Signature in Children With Cancer and Infection
Rigshospitalet, Denmark
FRANCiS-NF
The University of Hong Kong
Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Insel Gruppe AG, University Hospital Bern
PIPPIN
Peter MacCallum Cancer Centre, Australia
NEUTROSIS
University of Paris 13
ANTIBIONEED
Assistance Publique - Hôpitaux de Paris
THERMAL
Malaghan Institute of Medical Research
ORA-FEBRIS
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy
Insel Gruppe AG, University Hospital Bern
Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
Poitiers University Hospital
Hemato-Vanco
Ciusss de L'Est de l'Île de Montréal
Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
Asan Medical Center
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Indonesia University
Various G-CSF Regimens to Prevent Infection During Chemotherapy
Academisch Ziekenhuis Maastricht
SHORT
Amsterdam UMC, location VUmc
Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia
Hospital Infantil de Mexico Federico Gomez
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
Stanford University
DALFEN
All India Institute of Medical Sciences
G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients
Peking Union Medical College Hospital
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
Zhejiang Cancer Hospital
Long-acting G-CSF for Febrile Neutropenia
Peking Union Medical College Hospital
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
M.D. Anderson Cancer Center
Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia
Universidad Nacional Autonoma de Mexico